TIDMGSK
RNS Number : 3631K
GlaxoSmithKline PLC
04 May 2022
GlaxoSmithKline plc
Results of 22(nd) Annual General Meeting
GlaxoSmithKline plc ('GSK') held a hybrid Annual General Meeting
('AGM') at 2.30pm on Wednesday 4 May 2022. Shareholders were able
to join virtually via Lumi, Zoom and in person at the meeting held
at the Sofitel Hotel in Terminal 5 Heathrow.
All valid proxy votes (whether submitted electronically or in
hard copy form) were included in the poll taken at the meeting.
The table below shows the results of the poll on all 28
resolutions. The full text of the resolutions is contained in the
Notice of AGM published on 28 March 2022, which is available on
GSK's website at www.gsk.com .
Resolution Total votes % Total votes % Total votes Votes
for (1)(2) against cast withheld
(2) (3)
Receive and adopt
the 2021 Annual
1 Report 3,524,582,633 99.01 35,137,552 0.99 3,559,720,185 11,843,164
------------------------- -------------- ------ -------------- ------ -------------- -----------
Approve the Annual
2 report on remuneration 3,240,737,115 91.05 318,510,405 8.95 3,559,247,520 12,317,062
------------------------- -------------- ------ -------------- ------ -------------- -----------
Approve the Remuneration
3 Policy 2,197,755,545 61.76 1,360,515,540 38.24 3,558,271,085 13,294,793
------------------------- -------------- ------ -------------- ------ -------------- -----------
Election of Dr
4 Anne Beal 3,546,443,179 99.55 16,055,842 0.45 3,562,499,021 9,042,781
------------------------- -------------- ------ -------------- ------ -------------- -----------
Election of Dr
5 Harry Dietz 3,545,845,271 99.54 16,469,238 0.46 3,562,314,509 9,224,475
------------------------- -------------- ------ -------------- ------ -------------- -----------
Re-election of
6 Sir Jonathan Symonds 3,482,374,837 97.76 79,898,313 2.24 3,562,273,150 9,274,730
------------------------- -------------- ------ -------------- ------ -------------- -----------
Re-election of
7 Dame Emma Walmsley 3,555,195,651 99.79 7,564,971 0.21 3,562,760,622 8,806,465
------------------------- -------------- ------ -------------- ------ -------------- -----------
Re-election of
8 Charles Bancroft 3,503,934,446 98.36 58,393,472 1.64 3,562,327,918 9,214,474
------------------------- -------------- ------ -------------- ------ -------------- -----------
Re-election of
9 Vindi Banga 3,483,288,426 97.79 78,881,291 2.21 3,562,169,717 9,373,841
------------------------- -------------- ------ -------------- ------ -------------- -----------
Re-election of
10 Dr Hal Barron 3,546,018,185 99.54 16,347,031 0.46 3,562,365,216 9,173,855
------------------------- -------------- ------ -------------- ------ -------------- -----------
Re-election of
11 Dr Vivienne Cox 3,531,865,048 99.14 30,474,324 0.86 3,562,339,372 9,204,548
------------------------- -------------- ------ -------------- ------ -------------- -----------
Re-election of
12 Lynn Elsenhans 3,476,281,291 97.58 86,142,909 2.42 3,562,424,200 9,118,541
------------------------- -------------- ------ -------------- ------ -------------- -----------
Re-election of
13 Dr Laurie Glimcher 3,556,622,114 99.84 5,547,225 0.16 3,562,169,339 9,375,696
------------------------- -------------- ------ -------------- ------ -------------- -----------
Re-election of
14 Dr Jesse Goodman 3,555,655,121 99.82 6,515,409 0.18 3,562,170,530 9,367,820
------------------------- -------------- ------ -------------- ------ -------------- -----------
Re-election of
15 Iain Mackay 3,551,784,186 99.71 10,432,989 0.29 3,562,217,175 9,333,434
------------------------- -------------- ------ -------------- ------ -------------- -----------
Re-election of
16 Urs Rohner 3,410,175,068 95.74 151,806,419 4.26 3,561,981,487 9,561,680
------------------------- -------------- ------ -------------- ------ -------------- -----------
Re-appointment
17 of the auditor 3,557,280,686 99.84 5,797,033 0.16 3,563,077,719 8,481,780
------------------------- -------------- ------ -------------- ------ -------------- -----------
Remuneration of
18 the auditor 3,555,233,064 99.86 5,000,395 0.14 3,560,233,459 11,338,880
------------------------- -------------- ------ -------------- ------ -------------- -----------
Authority for the
company to make
donations to political
organisations and
incur political
19 expenditure 3,493,409,287 98.64 48,161,797 1.36 3,541,571,084 30,003,446
------------------------- -------------- ------ -------------- ------ -------------- -----------
Authority to allot
20 shares 3,430,993,149 96.35 130,127,471 3.65 3,561,120,620 10,593,875
------------------------- -------------- ------ -------------- ------ -------------- -----------
Disapplication
of pre-emption
rights - general
21 power (4) 3,460,375,320 97.24 98,220,644 2.76 3,558,595,964 12,963,416
------------------------- -------------- ------ -------------- ------ -------------- -----------
Disapplication
of pre-emption
rights - in connection
with an acquisition
or specified capital
22 investment (4) 3,404,168,390 95.65 154,942,194 4.35 3,559,110,584 12,448,092
------------------------- -------------- ------ -------------- ------ -------------- -----------
Authority for the
company to purchase
its own shares
23 (4) 3,517,497,794 98.79 43,085,674 1.21 3,560,583,468 10,990,502
------------------------- -------------- ------ -------------- ------ -------------- -----------
Exemption from
statement of senior
statutory auditor's
24 name 3,523,554,816 99.59 14,359,955 0.41 3,537,914,771 33,655,391
------------------------- -------------- ------ -------------- ------ -------------- -----------
Authority for reduced
notice of a general
meeting other than
25 an AGM (4) 3,331,432,180 93.62 227,176,994 6.38 3,558,609,174 12,950,914
------------------------- -------------- ------ -------------- ------ -------------- -----------
Approve the Share
26 Save Plan 2022 3,508,449,940 98.62 49,235,709 1.38 3,557,685,649 13,896,262
------------------------- -------------- ------ -------------- ------ -------------- -----------
Approve the Share
27 Reward Plan 2022 3,516,666,377 98.86 40,690,090 1.14 3,557,356,467 14,160,284
------------------------- -------------- ------ -------------- ------ -------------- -----------
Approve the adoption
of new Articles
of Association
28 (4) 3,549,030,121 99.80 6,964,097 0.20 3,555,994,218 15,501,889
------------------------- -------------- ------ -------------- ------ -------------- -----------
Resolution 3 - Approval of the Remuneration Policy
The Company was pleased that the new remuneration policy was
supported in a vote at today's Annual General Meeting. It also
notes that a significant minority were not able to support the new
policy at this time. The Company undertook an in-depth consultation
process with the majority of its largest shareholders in developing
the revised policy and will continue to engage to ensure it fully
understands the views of all shareholders on these matters, and to
continue to explain the rationale for the changes.
Notes:
(1) The "for" votes include those giving the Chair discretion.
In line with the notification issued to American Depositary Receipt
(ADR) holders last year, GSK did not instruct its ADR Depositary to
vote any unvoted ADRs in respect of the AGM resolutions.
(2) Votes "for" and "against" are expressed as a percentage of the total votes cast.
(3) A vote withheld is not a vote in law and is not counted in
the calculation of the proportion of votes "for" or "against" a
resolution.
(4) Indicates Special Resolutions requiring a 75% majority.
The following table provides further information on
participation in the AGM:
GSK's GSK's
Twenty second Twenty first
AGM AGM
(Hybrid meeting) (Virtual meeting)
(2022) (2021)
Issued share capital (excluding Treasury
Shares) 5,083,974,547 5,031,444,276
------------------- --------------------
Total votes cast and votes withheld
lodged as a % of GSK's issued share
capital (excluding Treasury Shares) 70.25% 70.11%
------------------- --------------------
Total shareholder population 89,764 100,906
------------------- --------------------
Total number of proxies lodged 5,343 6,089
------------------- --------------------
Number of shareholders in attendance 93 in person 142 participated
68 participated virtually
virtually
------------------- --------------------
% of shareholders who lodged proxies 5.95% 6.03%
------------------- --------------------
The above poll results will shortly be available on the
company's website at www.gsk.com . In accordance with Listing Rule
9.6.2, a copy of the resolutions, other than those concerning
ordinary business, will be submitted to the UK Listing Authority
and will in due course be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
V A Whyte
Company Secretary
4 May 2022
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGBKQBQABKDAPK
(END) Dow Jones Newswires
May 04, 2022 12:49 ET (16:49 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024
